39.36
-0.05(-0.13%)
Currency In USD
| Previous Close | 39.41 |
| Open | 39.09 |
| Day High | 40.02 |
| Day Low | 37.8 |
| 52-Week High | 90.32 |
| 52-Week Low | 36.89 |
| Volume | 1.44M |
| Average Volume | 1.53M |
| Market Cap | 2.11B |
| PE | -22.49 |
| EPS | -1.75 |
| Moving Average 50 Days | 45.12 |
| Moving Average 200 Days | 63.85 |
| Change | -0.05 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $86.74 as of February 21, 2026 at a share price of $39.36. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $182.22 as of February 21, 2026 at a share price of $39.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
GlobeNewswire Inc.
Feb 11, 2026 1:00 PM GMT
REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its fourt
Soleno Therapeutics to Participate in Upcoming Conferences
GlobeNewswire Inc.
Jan 29, 2026 1:00 PM GMT
REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in t
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 12:00 PM GMT
REDWOOD CITY, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced select preliminary financial an